vs
Side-by-side financial comparison of Paylocity Holding Corp (PCTY) and Bio-Techne (TECH). Click either name above to swap in a different company.
Paylocity Holding Corp is the larger business by last-quarter revenue ($387.0M vs $295.9M, roughly 1.3× Bio-Techne). Paylocity Holding Corp runs the higher net margin — 13.0% vs 12.8%, a 0.1% gap on every dollar of revenue. On growth, Paylocity Holding Corp posted the faster year-over-year revenue change (11.3% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.7%).
Paylocity Holding Corporation is an American provider of cloud-based payroll, , spend management, and human capital management (HCM) software.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PCTY vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $387.0M | $295.9M |
| Net Profit | $50.2M | $38.0M |
| Gross Margin | 72.9% | 64.6% |
| Operating Margin | 18.2% | 18.4% |
| Net Margin | 13.0% | 12.8% |
| Revenue YoY | 11.3% | -6.4% |
| Net Profit YoY | 34.0% | 68.3% |
| EPS (diluted) | $0.92 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $387.0M | $295.9M | ||
| Q3 25 | $378.9M | — | ||
| Q2 25 | $369.9M | $317.0M | ||
| Q1 25 | $421.1M | $316.2M | ||
| Q4 24 | $347.7M | $297.0M | ||
| Q3 24 | $333.1M | $289.5M | ||
| Q2 24 | $324.7M | $306.1M | ||
| Q1 24 | $366.8M | $303.4M |
| Q4 25 | $50.2M | $38.0M | ||
| Q3 25 | $48.0M | — | ||
| Q2 25 | $48.6M | $-17.7M | ||
| Q1 25 | $91.5M | $22.6M | ||
| Q4 24 | $37.5M | $34.9M | ||
| Q3 24 | $49.6M | $33.6M | ||
| Q2 24 | $48.8M | $40.6M | ||
| Q1 24 | $85.3M | $49.1M |
| Q4 25 | 72.9% | 64.6% | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 73.5% | 62.7% | ||
| Q1 25 | 77.1% | 67.9% | ||
| Q4 24 | 72.6% | 65.3% | ||
| Q3 24 | 74.4% | 63.2% | ||
| Q2 24 | 74.0% | 66.4% | ||
| Q1 24 | 77.8% | 67.4% |
| Q4 25 | 18.2% | 18.4% | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 17.9% | -7.5% | ||
| Q1 25 | 30.2% | 12.2% | ||
| Q4 24 | 13.4% | 16.0% | ||
| Q3 24 | 19.3% | 13.8% | ||
| Q2 24 | 19.4% | 15.0% | ||
| Q1 24 | 29.0% | 22.1% |
| Q4 25 | 13.0% | 12.8% | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 13.1% | -5.6% | ||
| Q1 25 | 21.7% | 7.1% | ||
| Q4 24 | 10.8% | 11.7% | ||
| Q3 24 | 14.9% | 11.6% | ||
| Q2 24 | 15.0% | 13.3% | ||
| Q1 24 | 23.3% | 16.2% |
| Q4 25 | $0.92 | $0.24 | ||
| Q3 25 | $0.86 | — | ||
| Q2 25 | $0.87 | $-0.11 | ||
| Q1 25 | $1.61 | $0.14 | ||
| Q4 24 | $0.66 | $0.22 | ||
| Q3 24 | $0.88 | $0.21 | ||
| Q2 24 | $0.85 | $0.26 | ||
| Q1 24 | $1.50 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $162.5M | $172.9M |
| Total DebtLower is stronger | $81.3M | $260.0M |
| Stockholders' EquityBook value | $1.1B | $2.0B |
| Total Assets | $7.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.07× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $162.5M | $172.9M | ||
| Q3 25 | $165.2M | — | ||
| Q2 25 | $398.1M | $162.2M | ||
| Q1 25 | $477.8M | $140.7M | ||
| Q4 24 | $482.4M | $177.5M | ||
| Q3 24 | $778.5M | $187.5M | ||
| Q2 24 | $401.8M | $152.9M | ||
| Q1 24 | $492.7M | $145.3M |
| Q4 25 | $81.3M | $260.0M | ||
| Q3 25 | $81.3M | — | ||
| Q2 25 | $162.5M | $346.0M | ||
| Q1 25 | $243.8M | $330.0M | ||
| Q4 24 | $325.0M | $300.0M | ||
| Q3 24 | $325.0M | $300.0M | ||
| Q2 24 | $0 | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $1.1B | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.0B | $2.1B | ||
| Q1 24 | $1.1B | $2.0B |
| Q4 25 | $7.0B | $2.5B | ||
| Q3 25 | $4.2B | — | ||
| Q2 25 | $4.4B | $2.6B | ||
| Q1 25 | $5.2B | $2.6B | ||
| Q4 24 | $5.3B | $2.7B | ||
| Q3 24 | $4.0B | $2.7B | ||
| Q2 24 | $4.2B | $2.7B | ||
| Q1 24 | $5.0B | $2.7B |
| Q4 25 | 0.07× | 0.13× | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.13× | 0.18× | ||
| Q1 25 | 0.20× | 0.16× | ||
| Q4 24 | 0.28× | 0.14× | ||
| Q3 24 | 0.29× | 0.14× | ||
| Q2 24 | 0.00× | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $117.0M | — |
| Free Cash FlowOCF − Capex | $113.6M | — |
| FCF MarginFCF / Revenue | 29.4% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $461.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $117.0M | — | ||
| Q3 25 | $86.5M | — | ||
| Q2 25 | $86.6M | $98.2M | ||
| Q1 25 | $186.0M | $41.1M | ||
| Q4 24 | $54.2M | $84.3M | ||
| Q3 24 | $91.5M | $63.9M | ||
| Q2 24 | $79.9M | $75.5M | ||
| Q1 24 | $167.5M | $81.0M |
| Q4 25 | $113.6M | — | ||
| Q3 25 | $82.7M | — | ||
| Q2 25 | $81.1M | $93.3M | ||
| Q1 25 | $183.7M | $31.0M | ||
| Q4 24 | $51.2M | $77.5M | ||
| Q3 24 | $89.1M | $54.7M | ||
| Q2 24 | $73.6M | $57.5M | ||
| Q1 24 | $162.0M | $64.5M |
| Q4 25 | 29.4% | — | ||
| Q3 25 | 21.8% | — | ||
| Q2 25 | 21.9% | 29.4% | ||
| Q1 25 | 43.6% | 9.8% | ||
| Q4 24 | 14.7% | 26.1% | ||
| Q3 24 | 26.8% | 18.9% | ||
| Q2 24 | 22.7% | 18.8% | ||
| Q1 24 | 44.2% | 21.3% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.5% | 1.5% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.9% | 2.3% | ||
| Q3 24 | 0.7% | 3.2% | ||
| Q2 24 | 1.9% | 5.9% | ||
| Q1 24 | 1.5% | 5.4% |
| Q4 25 | 2.33× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | 1.78× | — | ||
| Q1 25 | 2.03× | 1.82× | ||
| Q4 24 | 1.45× | 2.42× | ||
| Q3 24 | 1.84× | 1.90× | ||
| Q2 24 | 1.64× | 1.86× | ||
| Q1 24 | 1.96× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCTY
| Recurring Fees | $370.1M | 96% |
| Implementation Services And Other | $16.9M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
